Conduit Pharmaceuticals Inc. (NASDAQ:CDT), a clinical stage life science company with a current market capitalization of $7.49 million, announced that it will implement a 1-for-100 reverse stock split ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback